Physician profile
James P Loftin
NPI 1194793612
$1,918.26
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $12.70 · 2021: $184 · 2022: $521 · 2023: $818 · 2024: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $947.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $276.76 | 2021-2024 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $274.07 | 2019-2024 | Breztri, Airsupra, Fasenra |
| Electromed, INC. | $203.31 | 2019-2023 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $168.10 | 2019-2023 | Dupixent |
| Mylan Specialty L.P. | $162.43 | 2021-2024 | Yupelri |
| Harmony Biosciences LLC | $130.03 | 2021-2023 | Wakix |
| Baxter Healthcare | $115.18 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Visivest Airway Clearance System |
| Genzyme Corporation | $98.53 | 2022-2023 | |
| Axsome Therapeutics, INC. | $77.60 | 2023 | Sunosi |
| Amgen INC. | $67.12 | 2022-2024 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.03 | 2022-2023 | Ofev |
| Insmed, INC. | $41.26 | 2019-2021 | |
| Circassia INC. | $37.75 | 2019 | |
| Inogen, INC. | $37.29 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Inspire Medical Systems, INC. | $35.43 | 2023 | Inspire |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $29.93 | 2019 | |
| Philips North America LLC | $28.00 | 2023 | |
| Merck Sharp & Dohme LLC | $25.40 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $19.70 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.99 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Loftin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.